Market Overview:
The global oral mucositis market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, rising demand for better treatment options, and growing awareness about oral mucositis. The global oral mucositis market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into mouthwash, pain control medication, and other products. The mouthwash segment is expected to grow at a CAGR of 6% from 2018 to 2030 due to its ability to prevent or reduce the severity of oral mucositis symptoms.
Product Definition:
Oral mucositis is a common complication of cancer chemotherapy and radiation therapy. It is characterized by inflammation and ulceration of the mucous membranes lining the mouth and throat. Oral mucositis can make it very difficult to eat, drink, or speak. It can also lead to infection and sepsis. Oral mucositis is a common complication of cancer chemotherapy and radiation therapy. It is characterized by inflammation and ulceration of the mucous membranes lining the mouth and throat. Oral Mucositis can make it very difficult to eat, drink, or speak.
Mouthwash:
Mouthwash is a liquid or gel used to wash the mouth. It can be alcoholic or non-alcoholic. Alcoholic mouthwashes are usually more effective as they contain an active ingredient that helps kill bacteria. The alcohol content in these products makes them less suitable for children and people with sensitive gums, however, they can cause irritation to the eyes and throat if ingested.
Pain Control Medication:
Pain control medication is used to reduce or eliminate pain. It can be used in cases of acute as well as chronic pain. The most commonly prescribed medications are non-narcotic based analgesics which include aspirin, acetaminophen, ibuprofen and naproxen among others.
Application Insights:
Based on the application, the global market is segmented into hospitals, specialty clinics and others. Hospitals held the largest share in 2017 owing to high prevalence of chronic diseases such as diabetes and cancer that require long-term care. Moreover, a large patient base with moderate financial resources makes it convenient for manufacturers to invest in developing products for oral mucositis treatment in hospital settings.
The specialty clinics are anticipated to witness lucrative growth over the forecast period due to increasing number of patients suffering from chronic conditions requiring specialized treatment facilities at an outpatient level. For instance, according to a study published by NCBI in 2018 regarding oral mucositis caused by tongue cancer surgery, out of total 1% patients suffer from OM each year globally while this number jumps up to 15% among Asian population due largely geographic factors along with other reasons such as language barrier and less awareness about oral hygiene among affected individuals living in Asia Pacific region.
Regional Analysis:
Europe dominated the global market in 2017. The presence of well-established healthcare facilities, high awareness levels coupled with relatively higher healthcare expenditure levels and availability of advanced treatment options are some factors responsible for its large share. In addition, favorable reimbursement policies in this region are also expected to propel market growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing geriatric population and rising incidences of cancer among them which results in oral mucositis as a secondary condition. Moreover, improving infrastructure and growing medical tourism industry will also boost demand for these products over the coming years.
Growth Factors:
- Increasing incidence of cancer: The incidence of oral mucositis is increasing with the increase in the number of cancer patients. Oral mucositis is a common complication in cancer patients receiving radiation therapy or chemotherapy.
- Growing awareness about oral mucositis: There is growing awareness among people about oral mucositis and its complications. This is driving them to seek early diagnosis and treatment for the condition.
- Development of new therapies: There are several ongoing researches on developing new therapies for oral mucositis, which should help to improve the treatment options for this condition in future.
- Rising demand for stem cell therapy: Stem cell therapy has emerged as a promising treatment option for various diseases, including oral mucositis. This is likely to drive the demand for stem cell therapy in future, leading to growth of the Oral Mucositis market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Mucositis Market Research Report
By Type
Mouthwash, Pain Control Medication, Other
By Application
Hospitals, Specialty Clinics, Others
By Companies
GSK, Pfizer, Colgate-Palmolive, Norgine, Sobi, Bausch Health, EUSA Pharma, Camurus, Innovation Pharmaceuticals, Clinigen Group, Helsinn Healthcare, Alliance Pharma, Amag Pharmaceuticals, Oragenics, Soligenix, Himalaya
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Oral Mucositis Market Report Segments:
The global Oral Mucositis market is segmented on the basis of:
Types
Mouthwash, Pain Control Medication, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Pfizer
- Colgate-Palmolive
- Norgine
- Sobi
- Bausch Health
- EUSA Pharma
- Camurus
- Innovation Pharmaceuticals
- Clinigen Group
- Helsinn Healthcare
- Alliance Pharma
- Amag Pharmaceuticals
- Oragenics
- Soligenix
- Himalaya
Highlights of The Oral Mucositis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mouthwash
- Pain Control Medication
- Other
- By Application:
- Hospitals
- Specialty Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Mucositis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral mucositis is a condition that results when the lining of the mouth becomes inflamed. This can happen due to a number of factors, including infection, chemotherapy, radiation therapy, and surgery. Oral mucositis can cause pain and difficulty swallowing. It may also lead to decreased appetite and weight loss.
Some of the key players operating in the oral mucositis market are GSK, Pfizer, Colgate-Palmolive, Norgine, Sobi, Bausch Health, EUSA Pharma, Camurus, Innovation Pharmaceuticals, Clinigen Group, Helsinn Healthcare, Alliance Pharma, Amag Pharmaceuticals, Oragenics, Soligenix, Himalaya.
The oral mucositis market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oral Mucositis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oral Mucositis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oral Mucositis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oral Mucositis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oral Mucositis Market Size & Forecast, 2018-2028
4.5.1 Oral Mucositis Market Size and Y-o-Y Growth
4.5.2 Oral Mucositis Market Absolute $ Opportunity
Chapter 5 Global Oral Mucositis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Oral Mucositis Market Size Forecast by Type
5.2.1 Mouthwash
5.2.2 Pain Control Medication
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Oral Mucositis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Oral Mucositis Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oral Mucositis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oral Mucositis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Oral Mucositis Analysis and Forecast
9.1 Introduction
9.2 North America Oral Mucositis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Oral Mucositis Market Size Forecast by Type
9.6.1 Mouthwash
9.6.2 Pain Control Medication
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Oral Mucositis Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Oral Mucositis Analysis and Forecast
10.1 Introduction
10.2 Europe Oral Mucositis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Oral Mucositis Market Size Forecast by Type
10.6.1 Mouthwash
10.6.2 Pain Control Medication
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Oral Mucositis Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Oral Mucositis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Oral Mucositis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Oral Mucositis Market Size Forecast by Type
11.6.1 Mouthwash
11.6.2 Pain Control Medication
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Oral Mucositis Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Oral Mucositis Analysis and Forecast
12.1 Introduction
12.2 Latin America Oral Mucositis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Oral Mucositis Market Size Forecast by Type
12.6.1 Mouthwash
12.6.2 Pain Control Medication
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Oral Mucositis Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Oral Mucositis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Oral Mucositis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Oral Mucositis Market Size Forecast by Type
13.6.1 Mouthwash
13.6.2 Pain Control Medication
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Oral Mucositis Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oral Mucositis Market: Competitive Dashboard
14.2 Global Oral Mucositis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GSK
14.3.2 Pfizer
14.3.3 Colgate-Palmolive
14.3.4 Norgine
14.3.5 Sobi
14.3.6 Bausch Health
14.3.7 EUSA Pharma
14.3.8 Camurus
14.3.9 Innovation Pharmaceuticals
14.3.10 Clinigen Group
14.3.11 Helsinn Healthcare
14.3.12 Alliance Pharma
14.3.13 Amag Pharmaceuticals
14.3.14 Oragenics
14.3.15 Soligenix
14.3.16 Himalaya
